Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis - 08/02/17
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 11 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Background and objectives |
Transcatheter arterial chemoembolization (TACE) is the first-line treatment for unresectable hepatocellular carcinoma (HCC). It consists of conventional TACE (cTACE) and drug-eluting beads TACE (DEB-TACE). The comparative outcomes of the two methods remain controversial. The study aim to research the optimal TACE strategy for unresectable HCC.
Methods |
A systematic search of keywords, including ‘HCC’ and ‘drug-eluting beads’ was performed including four electronic databases: PubMed, Embase, China Biological Medicine Database (CBM), and Cochrane library databases from the date of inception to December 25, 2015. Review Manager 5.3 was used to calculate the pooled relative risks (RRs) and 95% confident intervals (CIs).
Results |
Sixteen cohort studies (4 RCTs, 3 prospective cohorts, 9 retrospective cohorts) were included comprising a total of 1832 patients: 822 patients with DEB-TACE therapy and 1010 patients undergoing cTACE. The 1-, 2-, and 3-year overall survival (OS) rates and 1- and 2-year relapse-free survival (RFS) rates were significantly higher in DEB-TACE group, with pooled RRs of 1.12 (95% CI=1.03–1.23, P=0.007), 1.26 (95% CI=1.03–1.54, P=0.02), 1.69 (95% CI=1.00–2.84, P=0.04), 1.21 (95% CI=1.01–1.44, P=0.03) and 1.68 (95% CI=1.17–2.43, P=0.005). There was no statistical significance in 3-year RFS, tumor response and treatment-related adverse events.
Conclusion |
Compared with cTACE, DEB-TACE therapy significantly improved 1-, 2-, and 3-year OS rates and the 1- and 2-year RFS rates.
Le texte complet de cet article est disponible en PDF.Plan
Vol 41 - N° 1
P. 75-85 - février 2017 Retour au numéro
Article précédent
- The association of the vitamin D status with the persistence of anti-HBs antibody at 20 years after primary vaccination with recombinant hepatitis B vaccine in infancy
- A. Jafarzadeh, J. Keshavarz, M. Bagheri-Jamebozorgi, M. Nemati, R. Frootan, F. Shokri
- Effect of ceramide-1-phosphate transfer protein on intestinal bacterial translocation in severe acute pancreatitis
- Jiang Wang, Chang Li, Yingjian Jiang, Hongmei Zheng, Dehui Li, Yibo Liang, Wensheng Deng, Dianliang Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?